228 related articles for article (PubMed ID: 29950532)
1. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.
Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S
Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532
[TBL] [Abstract][Full Text] [Related]
2. Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus.
Ying L; Shen Y; Zhang Y; Wang Y; Liu Y; Yin J; Wang Y; Yin J; Zhu W; Bao Y; Zhou J
Diabetes Res Clin Pract; 2021 Jul; 177():108880. PubMed ID: 34058298
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
[TBL] [Abstract][Full Text] [Related]
4. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
5. Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study.
Pan J; Li Q; Zhang L; Jia L; Tang J; Bao Y; Jia W
J Diabetes Complications; 2014; 28(6):772-8. PubMed ID: 25073934
[TBL] [Abstract][Full Text] [Related]
6. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy.
Sato E; Mori F; Igarashi S; Abiko T; Takeda M; Ishiko S; Yoshida A
Diabetes Care; 2001 Mar; 24(3):479-82. PubMed ID: 11289471
[TBL] [Abstract][Full Text] [Related]
7. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
8. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
Nakamura N; Hasegawa G; Obayashi H; Yamazaki M; Ogata M; Nakano K; Yoshikawa T; Watanabe A; Kinoshita S; Fujinami A; Ohta M; Imamura Y; Ikeda T
Diabetes Res Clin Pract; 2003 Aug; 61(2):93-101. PubMed ID: 12951277
[TBL] [Abstract][Full Text] [Related]
9. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
[TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy.
Gholamhossein Y; Behrouz H; Asghar Z
Korean J Ophthalmol; 2014 Oct; 28(5):373-8. PubMed ID: 25276078
[TBL] [Abstract][Full Text] [Related]
11. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation index and its association with severity of diabetic retinopathy in type 2 diabetic subjects.
Anitha B; Sampathkumar R; Balasubramanyam M; Rema M
J Diabetes Complications; 2008; 22(4):261-6. PubMed ID: 18413194
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
15. The Correlation between the Level of Skin Advanced Glycation End Products in Type 2 Diabetes Mellitus and the Stages of Diabetic Retinopathy and the Types of Traditional Chinese Medicine Syndrome.
Zhang S; Ma P; Chen Q
Evid Based Complement Alternat Med; 2022; 2022():5193944. PubMed ID: 35845597
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus.
Fosmark DS; Torjesen PA; Kilhovd BK; Berg TJ; Sandvik L; Hanssen KF; Agardh CD; Agardh E
Metabolism; 2006 Feb; 55(2):232-6. PubMed ID: 16423631
[TBL] [Abstract][Full Text] [Related]
17. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
[TBL] [Abstract][Full Text] [Related]
18. Levels of Interleukin 27 and Interleukin 35 in the Serum and Vitreous of Patients with Proliferative Diabetic Retinopathy.
Yan A; You H; Zhang X
Ocul Immunol Inflamm; 2018; 26(2):273-279. PubMed ID: 27537610
[TBL] [Abstract][Full Text] [Related]
19. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
Kostolanská J; Jakus V; Barák L
J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.
Koga K; Yamagishi S; Okamoto T; Inagaki Y; Amano S; Takeuchi M; Makita Z
Int J Clin Pharmacol Res; 2002; 22(1):13-7. PubMed ID: 12395914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
